Skip to main content

What the FDA labels say about taking them together

Dextroamphetamine and methenamine

Dextroamphetamine's FDA label of November 26, 2025 names methenamine in its drug interactions section; the methenamine labels PlainMeds reads (2) do not name dextroamphetamine. The dextroamphetamine label: “Methenamine Therapy Urinary excretion of amphetamines is increased, and efficacy is reduced, by acidifying agents used in methenamine therapy.”

Check it at the source: the dextroamphetamine FDA label on DailyMed (effective November 26, 2025, Azurity Pharmaceuticals, Inc.); the methenamine FDA label on DailyMed (effective August 7, 2026, ANI Pharmaceuticals, Inc.).

What does the dextroamphetamine label say about methenamine?

Dextroamphetamine label, drug interactions

Methenamine Therapy Urinary excretion of amphetamines is increased, and efficacy is reduced, by acidifying agents used in methenamine therapy.

Source: FDA drug label (Zenzedi), Azurity Pharmaceuticals, Inc., effective November 26, 2025 (SPL set d6394df5-f2c9-47eb-b57e-f3e9cfd94f84), via openFDA; the full label on DailyMed

What does the methenamine label say about dextroamphetamine?

Methenamine's label (effective August 7, 2026) and its 1 other brand-application label do not name dextroamphetamine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Methenamine Hippurate), ANI Pharmaceuticals, Inc., effective August 7, 2026 (SPL set a3eeacd4-1983-49ec-a60d-3abaf505ce57), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Dextroamphetamine generic labelers
10Methenamine generic labelers
DextroamphetamineMethenamine
Labeled forADHDUrinary tract infections
Boxed warningYesNo
Pharmacy cost (NADAC)$0.373 per tablet 10 mg tablet$0.313 per tablet 1 g tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?